MedMira Builds European Sales Infrastructure

28-Nov-2005

MedMira Inc. announced that it has engaged Swiss-based Partner International to assist in strengthening its European Union (EU) distribution network in anticipation of CE Mark approval. With the CE approval process advancing according to schedule, MedMira is increasing its efforts in building a solid distribution network to realize sales immediately following CE approval for its MiraCare(TM) Rapid HIV Test (MiraCare(TM) HIV).

"We were looking for a partner that could act as an extension of our Sales & Marketing team to help us realize immediate product sales in the EU. Partner International's in-depth industry experience coupled with their strong European and global business connections make them an ideal partner in this market," said Giles Crouch, vice president of sales and marketing for MedMira.

MedMira plans to stand alone as the only rapid diagnostics manufacturer in the world to obtain all key international regulatory approvals for its rapid HIV tests; from the United States Food and Drug Administration (FDA), Health Canada, China State Food and Drug Administration (SFDA) and soon, the European Union CE Mark.

Other news from the department business & finance

Most read news

More news from our other portals

Fighting cancer: latest developments and advances

See the theme worlds for related content

Topic world Diagnostics

Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.

10+ products
4 whitepaper
10+ brochures
View topic world

Topic world Diagnostics

Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.

10+ products
4 whitepaper
10+ brochures